Roche Holding Financials
| RHHBY Stock | USD 43.70 0.28 0.64% |
With this module, you can analyze Roche financials for your investing period. You should be able to track the changes in Roche Holding individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Roche |
The data published in Roche Holding's official financial statements typically reflect Roche Holding's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Roche Holding's quantitative information. For example, before you start analyzing numbers published by Roche accountants, it's essential to understand Roche Holding's liquidity, profitability, and earnings quality within the context of the Pharmaceuticals space in which it operates.
Please note, the imprecision that can be found in Roche Holding's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Roche Holding Ltd. Check Roche Holding's Beneish M Score to see the likelihood of Roche Holding's management manipulating its earnings.
Roche Holding Stock Summary
Roche Holding competes with Sanofi ADR, AstraZeneca PLC, GlaxoSmithKline PLC, Merck, and Novartis. Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company was founded in 1896 and is headquartered in Basel, Switzerland. Roche Holdings operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 100920 people.| Instrument | USA OTC Stock View All |
| Exchange | OTCQX Exchange |
| ISIN | US7711951043 |
| Business Address | Konzern Hauptsitz, Basel, |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.roche.com |
| Phone | 41 61 688 11 11 |
| Currency | USD - US Dollar |
Roche Holding Key Financial Ratios
Roche Holding's financial ratios allow both analysts and investors to convert raw data from Roche Holding's financial statements into concise, actionable information that can be used to evaluate the performance of Roche Holding over time and compare it to other companies across industries.| Return On Equity | 0.45 | |||
| Return On Asset | 0.15 | |||
| Target Price | 47.8 | |||
| Beta | 0.19 | |||
| Z Score | 9.0 |
Roche Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Roche Holding's current stock value. Our valuation model uses many indicators to compare Roche Holding value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Roche Holding competition to find correlations between indicators driving Roche Holding's intrinsic value. More Info.Roche Holding Ltd is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers reporting about 0.33 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Roche Holding Ltd is roughly 3.05 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Roche Holding by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Roche Holding's OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Roche Holding Systematic Risk
Roche Holding's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Roche Holding volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Roche Holding correlated with the market. If Beta is less than 0 Roche Holding generally moves in the opposite direction as compared to the market. If Roche Holding Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Roche Holding is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Roche Holding is generally in the same direction as the market. If Beta > 1 Roche Holding moves generally in the same direction as, but more than the movement of the benchmark.
Roche Holding March 22, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Roche Holding help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Roche Holding Ltd. We use our internally-developed statistical techniques to arrive at the intrinsic value of Roche Holding Ltd based on widely used predictive technical indicators. In general, we focus on analyzing Roche OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Roche Holding's daily price indicators and compare them against related drivers.
| Downside Deviation | 1.31 | |||
| Information Ratio | 0.275 | |||
| Maximum Drawdown | 5.52 | |||
| Value At Risk | (1.92) | |||
| Potential Upside | 2.63 |
Additional Tools for Roche OTC Stock Analysis
When running Roche Holding's price analysis, check to measure Roche Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Roche Holding is operating at the current time. Most of Roche Holding's value examination focuses on studying past and present price action to predict the probability of Roche Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Roche Holding's price. Additionally, you may evaluate how the addition of Roche Holding to your portfolios can decrease your overall portfolio volatility.